Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
Duke survives: Blue Devils defeat UConn Huskies in 4th-quarter comeback, 26-21
Just In
UNC runs away with it: Omarion Hampton leads Tar Heels to 45-10 win over NC Central. Hampton had 210 rushing yards and three rushing TDs
Program
On WRAL+ at 10: Man found dead under tree with rope around his neck. What a district attorney is saying. Watch WRAL News+ wherever you stream WRAL
Program
WRAL News at 10 will air on WRAL News+, antenna Ch. 34.1, Spectrum Ch. 1257 and in the WRAL News app on your smart TV or mobile device.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avista Public Acquisition Corp II Cl A
(NQ:
AHPA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Nov 1, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Avista Public Acquisition Corp II Cl A
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
October 31, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Via
Benzinga
Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients
August 25, 2022
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
October 28, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301.
Via
Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Ligand To Spin-Off OmniAb Via Avista Capital-Backed SPAC Merger
March 24, 2022
Ligand Pharmaceuticals Inc (NASDAQ: LGND)
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.